Table 4.
Top 15 PRS models associated with PTA12-16 (N = 218)
| PRS name | Reported trait | Beta | p | Adj p | Adj R2 |
|---|---|---|---|---|---|
| PGS001339 | Atrial fibrillation and flutter (time-to-event) | 5.01 | 1.8E-07 | 0.0003** | 0.12 |
| PGS001340 | Atrial fibrillation | 5.10 | 2.5E-07 | 0.0003** | 0.12 |
| PGS001263 | Atrial flutter | 4.96 | 3.9E-07 | 0.0003** | 0.11 |
| PGS002050 | Atrial fibrillation and flutter | 4.14 | 2.4E-05 | 0.015* | 0.08 |
| PGS000331 | Atrial fibrillation | 4.03 | 3.4E-05 | 0.017* | 0.07 |
| PGS001841 | Atrial fibrillation and flutter | 4.00 | 4.9E-05 | 0.021* | 0.07 |
| PGS000016 | Atrial fibrillation | 4.14 | 9.4E-05 | 0.035* | 0.07 |
| PGS002294 | Breast cancer | 3.20 | 0.001 | 0.32 | 0.05 |
| PGS001947 | Cystatin C | − 2.94 | 0.001 | 0.36 | 0.04 |
| PGS000035 | Atrial fibrillation | 2.95 | 0.001 | 0.42 | 0.04 |
| PGS000228 | Cathepsin L1 (CTSL1) serum levels | 2.82 | 0.001 | 0.42 | 0.04 |
| PGS000338 | Atrial fibrillation | 2.85 | 0.002 | 0.44 | 0.04 |
| PGS000050 | Breast cancer | 2.57 | 0.002 | 0.48 | 0.04 |
| PGS001356 | Atrial fibrillation | − 3.01 | 0.002 | 0.48 | 0.04 |
| PGS002165 | Cystatin C | − 2.84 | 0.002 | 0.48 | 0.04 |
Baseline model 1 (predictors: age, sex, ethnicity): adjusted R2 = 0.01, p > 0.05 (no predictors achieved statistical significance)
Baseline model 2 (predictors: age, sex, ethnicity, PCA1-5): adjusted R2 = 0.002, p > 0.05 (no predictors achieved statistical significance)
*p < 0.05, **p < 0.001